Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Safe Accelerated Venetoclax Escalation in CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
- Status
- RECRUITING
- Phase
- N/A
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Status
- RECRUITING
- Phase
- PHASE1
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ALICIA (Acalabrutinib in CLL Therapy)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)
- Status
- COMPLETED
- Phase
- PHASE2
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- N/A
Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Personalized Multi-peptide Vaccination in CLL Patients
- Status
- COMPLETED
- Phase
- PHASE1
huCART19-IL18 in CD19+ Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1